EN DE
STOCK COMPARISON

Artemis Gold vs Fresenius SE & Co. KGaA: Fair Value & Quality

Both stocks run through our valuation models. Here is how Artemis Gold (ARTG) and Fresenius SE & Co. KGaA (FRE) compare, as of Aug 10, 2026.

As of Aug 10, 2026, Fair Value Calculator sees Fresenius SE & Co. KGaA as the less overvalued of the two: Artemis Gold trades at C$41.17 versus a fair value of C$21.86 (-47%), while Fresenius SE & Co. KGaA trades at €47.06 versus €32.15 (-32%).
Artemis Gold
ARTG.V · CAD · Materials
-47%
upside to fair value
overvalued
PriceC$41.17
Fair ValueC$21.86
Quality59/100
Fresenius SE & Co. KGaA
FRE.XETRA · EUR · Health Care
-32%
upside to fair value
overvalued
Price€47.06
Fair Value€32.15
Quality57/100

Head-to-head numbers

Green value = the better side for that row (for valuation multiples: lower = cheaper).

Artemis GoldFresenius SE & Co. KGaA
Valuation
18.4×P/E (TTM)15.6×
5.01×P/S (TTM)1.18×
5.89×P/B1.42×
7.3×EV/EBITDA11.5×
PEG0.77×
Dividend yield2.5%
Dividend per share€1.05
Profitability
39%Net margin6%
68%Operating margin10%
53%Return on equity8%
23%Return on assets3%
Growth
668%Revenue growth (YoY)2%
Avg. growth/yr (3Y)2.4%
Avg. growth/yr (5Y)-8.8%
Balance & size
0.45×Debt / equity0.48×
$6BMarket cap$27B
weakGrowth qualityweak

Artemis Gold leads: 7 to 3 metric wins.

Dash = not meaningfully computable, for example with negative equity.

Quality in detail

The quality score, broken down into the same factor families as on the stock page, 0 to 100 per family.

Artemis Goldof which business quality 59 · market factors 56 Fresenius SE & Co. KGaAof which business quality 55 · market factors 61
ProfitabilityMargins and returns on capital today
70
32
Quality GrowthAre margins and returns improving?
100
57
CashflowEarnings quality: real cash, not paper profit
62
50
Fin. StrengthBalance sheet, leverage, solvency risk
71
45
InvestmentDisciplined investing over empire-building
0
92
Low VolatilityCalm price path (market factor)
18
78
MomentumPrice trend over the last 3–12 months (market factor)
65
50
52W MomentumDistance to the 52-week high (market factor)
85
62
Net IssuanceBuybacks instead of dilution
26
81

What the models say

The median fair value (base case) per model family, each in the currency of its trading venue. Green = above the current price, red = below.

Artemis Gold

DCF ModelsC$16.50
Earnings-BasedC$16.34
MultiplesC$19.25
Asset-BasedC$2.91
Growth DCFC$7.61
Economic ProfitC$20.87
Growth EarningsC$21.86

23 of 23 models see the stock below the current price.

Fresenius SE & Co. KGaA

DCF Models€28.71
Earnings-Based€17.93
Dividend Discount€16.93
Multiples€43.76
Asset-Based€22.73
Growth DCF€25.33
Economic Profit€23.30
Growth Earnings€39.20

21 of 25 models see the stock below the current price.

Scenario ranges

From our cautious bear case to the optimistic bull case. The white tick is the current price: left of fair value means room to run.

Artemis Gold
Bear C$10.19Fair Value C$21.86Bull C$28.42
C$41.17 = current price (white tick)
Fresenius SE & Co. KGaA
Bear €27.44Fair Value €32.15Bull €48.50
€47.06 = current price (white tick)

Compare two other stocks

Tap a field and type again, ticker or company name.

Free, no sign-up

Ranked within their sector

Where each stock sits within its sector peer group. Band = middle 50% of peers, tick = median, dot = this stock.

Artemis Gold · Materials

Quality score59 · Top 25%
Fair value upside-47% · below median

Fresenius SE & Co. KGaA · Health Care

Quality score57 · above median
Fair value upside-32% · below median

Bottom line

As of Aug 10, 2026, Fair Value Calculator sees Fresenius SE & Co. KGaA as the less overvalued of the two: Artemis Gold trades at C$41.17 versus a fair value of C$21.86 (-47%), while Fresenius SE & Co. KGaA trades at €47.06 versus €32.15 (-32%).

Artemis Gold has the higher quality score (59/100).

See the full analysis →

More comparisons

Popular match-ups from the same sectors, all with fair value and quality score.

Free · Top-25 report

See the undervalued quality stocks every month

Just your email for the monthly Top-25 report of the most undervalued quality stocks, with fair value, quality and price target. Plus 14 days of Pro to try, no card.

Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click. Not financial advice.

A model-based valuation snapshot from 21 models. Values change with price and fundamentals; the date shown above applies.